1 year return (CAGR)
-35.65%
Novo Nordisk A/S Exchange (NYSE, USD)
NVO
39.40
-3.44 (-7.96%)
HealthcareDrug Manufacturers - General
Loading...
3 year return (CAGR)
-25.55%
5 year return (CAGR)
-4.37%
10 year return (CAGR)
5.66%
Novo Nordisk (NVO) Stock Analysis and Outlook
Read MoreMarketcap
133.18B
Price/Sales
0.40
Ent value
462.36B
Price/Book
0.60
Div yield
2.91%
Growth years
3
Div growth
20.29%
FCF payout
68.62%
Trailing P/E
1.14
PEG
0.83
Forward P/E
1.81
EPS growth
19.72%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 41.05 |
| Daily high | 41.17 |
| Daily low | 39.54 |
| Daily Volume | 48.9M |
| All-time high | 146.91 |
| 1y analyst estimate | 47.23 |
| Beta | 0.35 |
| EPS (TTM) | 26.25 |
| Dividend per share | 1.16 |
| Ex-div date | 17 Aug 2026 |
| Next earnings date | 6 May 2026 |
Downside potential
Loading...
Downside potential data
| NVO | S&P500 | |
| Current price drop from All-time high | -73.18% | -0.58% |
| Highest price drop | -75.98% | -56.47% |
| Date of highest drop | 30 Mar 2026 | 9 Mar 2009 |
| Avg drop from high | -13.41% | -10.68% |
| Avg time to new high | 16 days | 12 days |
| Max time to new high | 1120 days | 1805 days |
News
